Mpox and Chickenpox Coinfection : Case Series From Southern Nigeria
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
BACKGROUND: We describe clinicoepidemiologic characteristics of mpox-chickenpox coinfection in Nigeria.
METHODS: A retrospective cohort analysis was performed of confirmed mpox cases in Nigeria from January 2022 to March 2023. Mpox and chickenpox were confirmed by real-time polymerase chain reaction (RT-PCR).
RESULTS: Of 94 (60.0%) suspected cases, 56 had confirmed mpox, of whom 16 (28.6%) had chickenpox coinfection. The median age of confirmed mpox cases was 29 years (interquartile range, 20-37 years), 24 were men (60.7%), 6 (10.7%) were bisexual, and 5 (8.9%) died. Mpox-chickenpox-coinfected patients had more complications than mpox-monoinfected cases (56.3% vs 22.5%, P = .015).
CONCLUSIONS: The high frequency of mpox-chickenpox coinfection argues for accelerated access to mpox and chickenpox vaccines in Africa.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:229 |
|---|---|
| Enthalten in: |
The Journal of infectious diseases - 229(2024), Supplement_2 vom: 26. März, Seite S260-S264 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mmerem, Juliet I [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Chickenpox |
|---|
| Anmerkungen: |
Date Completed 28.03.2024 Date Revised 28.03.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/infdis/jiad556 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36549027X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36549027X | ||
| 003 | DE-627 | ||
| 005 | 20240329000230.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/infdis/jiad556 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1353.xml |
| 035 | |a (DE-627)NLM36549027X | ||
| 035 | |a (NLM)38058122 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mmerem, Juliet I |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Mpox and Chickenpox Coinfection |b Case Series From Southern Nigeria |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.03.2024 | ||
| 500 | |a Date Revised 28.03.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
| 520 | |a BACKGROUND: We describe clinicoepidemiologic characteristics of mpox-chickenpox coinfection in Nigeria | ||
| 520 | |a METHODS: A retrospective cohort analysis was performed of confirmed mpox cases in Nigeria from January 2022 to March 2023. Mpox and chickenpox were confirmed by real-time polymerase chain reaction (RT-PCR) | ||
| 520 | |a RESULTS: Of 94 (60.0%) suspected cases, 56 had confirmed mpox, of whom 16 (28.6%) had chickenpox coinfection. The median age of confirmed mpox cases was 29 years (interquartile range, 20-37 years), 24 were men (60.7%), 6 (10.7%) were bisexual, and 5 (8.9%) died. Mpox-chickenpox-coinfected patients had more complications than mpox-monoinfected cases (56.3% vs 22.5%, P = .015) | ||
| 520 | |a CONCLUSIONS: The high frequency of mpox-chickenpox coinfection argues for accelerated access to mpox and chickenpox vaccines in Africa | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Nigeria | |
| 650 | 4 | |a chickenpox | |
| 650 | 4 | |a coinfection | |
| 650 | 4 | |a epidemiology | |
| 650 | 4 | |a mpox | |
| 650 | 4 | |a vaccine | |
| 700 | 1 | |a Umenzekwe, Chukwudi C |e verfasserin |4 aut | |
| 700 | 1 | |a Johnson, Simon M |e verfasserin |4 aut | |
| 700 | 1 | |a Onukak, Asukwo E |e verfasserin |4 aut | |
| 700 | 1 | |a Chika-Igwenyi, Nneka M |e verfasserin |4 aut | |
| 700 | 1 | |a Chukwu, Sunday K |e verfasserin |4 aut | |
| 700 | 1 | |a Onyeaghala, Chizaram A |e verfasserin |4 aut | |
| 700 | 1 | |a Ozougwu, Jideofor J |e verfasserin |4 aut | |
| 700 | 1 | |a Alasia, Datonye |e verfasserin |4 aut | |
| 700 | 1 | |a Ehiakhamen, Odianosen |e verfasserin |4 aut | |
| 700 | 1 | |a Nwankwo, Henry M |e verfasserin |4 aut | |
| 700 | 1 | |a Ezejiofor, Ogochukwu I |e verfasserin |4 aut | |
| 700 | 1 | |a Unigwe, Uche S |e verfasserin |4 aut | |
| 700 | 1 | |a Iroezindu, Michael O |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infectious diseases |d 1945 |g 229(2024), Supplement_2 vom: 26. März, Seite S260-S264 |w (DE-627)NLM000005819 |x 1537-6613 |7 nnns |
| 773 | 1 | 8 | |g volume:229 |g year:2024 |g number:Supplement_2 |g day:26 |g month:03 |g pages:S260-S264 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/infdis/jiad556 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 229 |j 2024 |e Supplement_2 |b 26 |c 03 |h S260-S264 | ||